Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia

被引：0
|
作者：
Kane, J. M. [1 ]
Mackle, M. [1 ]
Snow-Adami, L. [1 ]
Zhao, J. [1 ]
Szegedi, A. [1 ]
Panagides, J. [1 ]
机构：
[1] Zucker Hillside Hosp, Glen Oaks, NY USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [21] Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
    McIntyre, Roger S.
    Cohen, Miriam
    Zhao, Jun
    Alphs, Larry
    Macek, Thomas A.
    Panagides, John
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 122 (1-2) : 27 - 38
  • [22] "Extended" Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia: A Double-Blind, Placebo-Controlled Trial
    Remington, Gary
    Seeman, Philip
    Feingold, Alan
    Mann, Steve
    Shammi, Chekkera
    Kapur, Shitij
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (08) : 1042 - 1048
  • [23] Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patients
    Higuchi, Teruhiko
    Ishigooka, Jun
    Iyo, Masaomi
    Yeh, Chin-Bin
    Ebenezer, Esther Gunaseli
    Liang, Kuei Yu
    Lee, Jung Sik
    Lee, Sang Yeol
    Lin, Shih Ku
    Yoon, Bo-Hyun
    Nakamura, Masatoshi
    Hagi, Katsuhiko
    Sato, Takayuki
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (02)
  • [24] Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Shibre, Teshome
    Alem, Atalay
    Abdulahi, Abdulreshid
    Araya, Mesfin
    Beyero, Teferra
    Medhin, Girmay
    Deyassa, Negusse
    Negash, Alemayehu
    Nigatu, Alemayehu
    Kebede, Derege
    Fekadu, Abebaw
    SCHIZOPHRENIA BULLETIN, 2010, 36 (04) : 846 - 851
  • [25] Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial
    Ghanizadeh, Ahmad
    Rezaee, Zahra
    Dehbozorgi, Sara
    Berk, Michael
    Akhondzadeh, Shahin
    PSYCHIATRY RESEARCH, 2014, 219 (03) : 431 - 435
  • [26] Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
    Josiassen, RC
    Joseph, A
    Kohegyi, E
    Stokes, S
    Dadvand, M
    Paing, WW
    Shaughnessy, RA
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (01): : 130 - 136
  • [27] Primary negative symptoms in schizophrenia:: Treatment with paroxetine in a double-blind placebo-controlled trial
    Jockers-Scherübl, MC
    Godemann, F
    Bauer, A
    Wolfensteller, U
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [28] Fluoxetine treatment for prevention of relapse of depression in children and adolescents: A double-blind, placebo-controlled study
    Emslie, GJ
    Heiligenstein, JH
    Hoog, SL
    Wagner, KD
    Findling, RL
    McCracken, JT
    Nilsson, ME
    Jacobson, JG
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (11): : 1397 - 1405
  • [29] Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study
    Unfer, V
    Casini, ML
    Costabile, L
    Mignosa, M
    Gerli, S
    Di Renzo, GC
    FERTILITY AND STERILITY, 2004, 82 (01) : 145 - 148
  • [30] Long-term treatment of ulcerative colitis with ciprofloxacin:: A prospective, double-blind, placebo-controlled study
    Turunen, UM
    Färkkilä, MA
    Hakala, K
    Seppälä, K
    Sivonen, A
    Ögren, M
    Vuoristo, M
    Valtonen, VV
    Miettinen, TA
    GASTROENTEROLOGY, 1998, 115 (05) : 1072 - 1078
12345